baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

SHIONOGI + CO. LTD/ JP3347200002 /

2024-05-21 9:50:00 PM	Chg. -1.2000	Volume	Bid7:32:43 AM	Ask7:32:43 AM	Market Capitalization	Dividend Y.	P/E Ratio
40.6000EUR	-2.87%	0 Turnover: 0.0000	39.2000Bid Size: 150	40.6000Ask Size: 150	13.25 bill.EUR	-	-

GlobeNewswire 05-09 Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Ni...

GlobeNewswire 05-07 Apnimed Named 2024 Best Places to Work Company by the Boston Business Journal

GlobeNewswire 04-03 Apnimed to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire 03-06 Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference

GlobeNewswire 02-22 Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference

GlobeNewswire 02-19 InveniAI Announces Collaboration with Ono Pharmaceutical for Target Discovery

GlobeNewswire 02-07 Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discover...

GlobeNewswire 01-22 Apnimed Announces New Leadership Appointments as the Company Builds Its Commercial and Human Resourc...

GlobeNewswire 2023-11-10 Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine ...

GlobeNewswire 2023-11-01 Apnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for...

GlobeNewswire 2023-10-21 F2G and Shionogi Present Full Data Set from Pivotal Phase 2b Study at Trends in Medical Mycology (TI...

GlobeNewswire 2023-09-20 OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs

GlobeNewswire 2021-12-22 Zai Lab Announces Promotion of Harald Reinhart, M.D. to President and Head of Global Development, Ne...

GlobeNewswire 2021-11-04 Arcutis Announces Third Quarter 2021 Financial Results and Provides Business Update

TeleTrader 2021-11-01 Shionogi to start COVID vaccine Phase 3 trial

GlobeNewswire 2021-08-23 Bruce Binkowitz Joins Arcutis as Vice President of Biometrics

TeleTrader 2021-07-25 Japanese company tests anti-COVID drug - report

TeleTrader 2021-06-27 Japanese Shionogi to produce 60M doses in 2022

GlobeNewswire 2021-05-13 Metacrine Accelerates MET409 Clinical Development Milestone and Reports First-Quarter 2021 Results

GlobeNewswire 2021-04-27 InveniAI and Shionogi Enter AI-Powered Multi-Target Drug Discovery Collaboration

GlobeNewswire 2021-04-05 Metacrine Appoints Dr. Julia C. Owens to Its Board of Directors

GlobeNewswire 2021-02-05 CHNC Saga, Metamorphosis, and Transformation

GlobeNewswire 2020-11-13 AIM ImmunoTech Provides Third Quarter 2020 Business Update

GlobeNewswire 2020-10-30 BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year

GlobeNewswire 2020-07-23 Genocea Provides Second Quarter 2020 Corporate Update

SHIONOGI + CO. LTD/ JP3347200002 /

If you wish to receive reply to your feedback, please provide your email address.